JULIE HARNING: Open Payments
NPI 1336745884 · KALAMAZOO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,414 in 57 payments from 17 companies in 2025. Trend: 2023 $1,346 · 2024 $1,057 · 2025 $2,414
Food & beverage: $1,569Travel & lodging: $844
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 10 | $1,077 |
| GENZYME CORPORATION | 6 | $390 |
| ABBVIE INC. | 24 | $365 |
| EMD Serono, Inc. | 1 | $115 |
| Celgene Corporation | 4 | $111 |
| MDD US Operations, LLC | 1 | $101 |
| Lundbeck LLC | 1 | $43 |
| Dynasplint Systems Inc. | 1 | $25 |
| UCB, Inc. | 1 | $25 |
| Genentech USA, Inc. | 1 | $25 |
Products named: QULIPTA, Mavenclad, ZEPOSIA, UBRELVY, VYEPTI, Dynasplint, Fintepla, Ocrevus Zunovo.
Industry payments across MI — which companies pay providers there.
